Daniel T. Olive
Marseille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 189 publications
Correction: Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killing.
Journal: Cell death & disease
Published: January 21, 2026
The Phylogenomic Approach Suggests That Butyrophilins Have Ligands Beyond Gamma-Delta Receptors.
Journal: International journal of molecular sciences
Published: September 16, 2025
Combined IFN-γ and TNF-α treatment enhances the susceptibility of breast cancer cells and spheroids to Natural Killer cell-mediated killing.
Journal: Cell death & disease
Published: January 21, 2025
Immediate variations in high-dimensional circulating immune cells following pancreatectomy.
Journal: Clinical & translational immunology
Published: December 17, 2024
PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 13, 2024
Vγ9Vδ2 T Cells Express an Antitumor Profile Associated with Anti-PD-(L)1 Responses and Activation Defects Restored by Anti-BTN3A in Triple-Negative Breast Cancer.
Journal: Cancer immunology research
Published: December 13, 2024
Preoperative lymphocyte signature predicts pancreatic fistula after pancreatoduodenectomy.
Journal: Communications medicine
Published: October 19, 2024
Tertiary Lymphoid Structures Are Associated with Enhanced Macrophage Activation and Immune Checkpoint Expression and Predict Outcome in Cervical Cancer.
Journal: Cancer immunology research
Published: October 09, 2024
CD56neg CD16+ cells represent a distinct mature NK cell subset with altered phenotype and are associated with adverse clinical outcome upon expansion in AML.
Journal: Frontiers in immunology
Published: August 28, 2024
A beginner's guide to supervised analysis for mass cytometry data in cancer biology.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology
Published: June 10, 2024
ETx-22, a Novel Nectin-4-Directed Antibody-Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4-Expressing Tumors.
Journal: Cancer research communications
Published: March 22, 2024
Last Updated: 09/26/2026